Dr. Teresa Newsome Bondurant, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 985 9th Ave Southwest, Suite 201 Pob, Bessemer, AL 35022 Phone: 205-481-9339 Fax: 205-481-8558 |
Mrs. Latoya Drish Psychologist - Cognitive & Behavioral Medicare: Not Enrolled in Medicare Practice Location: 1012 Avenue J, Bessemer, AL 35020 Phone: 205-545-1816 |
Mr. Garrett Murray Jr. Psychologist - Mental Retardation & Developmental Disabilities Medicare: Not Enrolled in Medicare Practice Location: 416 19th St S, Bessemer, AL 35020 Phone: 770-861-8129 |
Dr. Cynthia Ann Neville, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 203 17th St N, Bessemer, AL 35020 Phone: 205-428-4771 |
News Archive
Researchers in Britain believe that children whose mothers had a low intake of vitamin E during pregnancy are more likely to develop wheezing and asthma by age five.
On Tuesday, February 9, kidney patients from across the state of Georgia will join Dialysis Patient Citizens (DPC) – a national, non-profit, patient-led organization representing approximately 1,300 members in Georgia and 22,000 members nationwide – in holding a briefing at the State Capitol, followed by a series of meetings with lawmakers and staff, urging the passage of key legislation this year that would help thousands of Georgia's kidney failure patients who are struggling to access health insurance for the medical care they need.
Researchers at Sandia National Laboratories are developing a medical instrument that will be able to quickly detect a suite of biothreat agents, including anthrax, ricin, botulinum, shiga and SEB toxin.
Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients today provided further updates on the business development of its flagship product: Gingko Mihuan Oral Liquid with the SFDA approval number: H20013079.
Seqirus announced today that the US Food and Drug Administration has approved Fluad (Influenza Vaccine, Adjuvanted) to help protect those aged 65 years and older against seasonal influenza. Fluad is the first adjuvanted seasonal influenza vaccine approved in the United States; it was specifically developed for the adult population aged 65 and older.
› Verified 8 days ago